Target intelligence / Profile preview

Hepatitis B virus small surface protein S (HBsAg (S protein))

Target
HBsAg (S protein)
Molecular classification
Viral structural protein, Membrane protein, Antigen
01

Overview

The "Hepatitis B virus S open reading frame transcript" refers to the mRNA transcribed from the S region of the hepatitis B virus genome. This transcript encodes the small surface antigen known as HBsAg or S protein. The major function of this viral membrane glycoprotein is to form both infectious virion envelopes and non-infectious subviral particles that circulate in high quantities during infection[5][8]. The presence of HBsAg in blood is a hallmark diagnostic marker for acute or chronic hepatitis B infection[6]. Recombinant forms of this antigen are used as immunogens in all current prophylactic HBV vaccines, which work by inducing protective antibody responses against this surface component[5][8]. **Note on correctness:** The query target "Hepatitis B virus S open reading frame transcript" describes an mRNA rather than a canonical therapeutic target such as a receptor or enzyme. However, its translation product—the small surface antigen/protein—is widely recognized as both an immunological biomarker and vaccine/drug target. For structured data purposes, it is best mapped to "Hepatitis B virus small surface protein S" or simply "HBsAg," not just its transcript[5][6][8]. If you need information about other related proteins encoded by different ORFs—such as pre-S1/pre-S2/L/M proteins—please specify further.

Other names
Hepatitis B virus S proteinHBV S antigenSmall hepatitis B surface antigenSHBsAg
02

Mechanism of action

Vaccines induce neutralizing antibodies against HBsAg, preventing viral entry into hepatocytes and conferring immunity.

03

Biological functions

Virus assembly and morphogenesisFormation of subviral particles (SVP)Induction of immune response (antibody production)Viral entry into host cells (as part of the envelope)
04

Disease associations

Infection (Hepatitis B)Biomarker for chronic hepatitis B infection and carrier state
05

Safety considerations

Vaccine-related allergic reactions are rare.Chronic presence in serum is associated with increased risk for liver cirrhosis and hepatocellular carcinoma due to persistent infection.
06

Interacting drugs

Hepatitis B vaccines (recombinant HBsAg-based vaccines)
07

Biomarkers

Serum HBsAg levels are used to diagnose active HBV infection, monitor treatment response, and assess risk of transmission.

Beyond the preview

Go deeper on Hepatitis B virus small surface protein S (HBsAg (S protein)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatitis B virus small surface protein S (HBsAg (S protein)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call